Ogura, Michinori
Ishizawa, Kenichi
Maruyama, Dai
Uike, Naokuni
Ando, Kiyoshi
Izutsu, Koji
Terui, Yasuhito
Imaizumi, Yoshitaka
Tsukasaki, Kunihiro
Suzuki, Kenshi
Izumi, Tohru
Usuki, Kensuke
Kinoshita, Tomohiro
Taniwaki, Masafumi
Uoshima, Nobuhiko
Suzumiya, Junji
Kurosawa, Mitsutoshi
Nagai, Hirokazu
Uchida, Toshiki
Fukuhara, Noriko
Choi, Ilseung
Ohmachi, Ken
Yamamoto, Go
Tobinai, Kensei
,
Article History
Received: 29 September 2016
Revised: 11 November 2016
Accepted: 13 November 2016
First Online: 29 November 2016
Compliance with ethical standards
:
: Dr. Ogura has received research funding from SymBio; and has received honoraria from Takeda, Mundipharma, Meiji Seika Pharma, and Celgene. Dr. Ishizawa has received research funding from Kyowa Hakko Kirin, MSD, Celgene, and Pfizer; and has received honoraria form Kyowa Hakko Kirin, Chugai, and Takeda. Dr. Maruyama has received honoraria from Eisai, Takeda, Chugai, Janssen, Nippon Kayaku, Celgene, Mundipharma, Sanofi, Kyowa Hakko Kirin, Mochida, and Ono. Dr. Ando has received research funding form Kyowa Hakko Kirin. Dr. Izutsu has received honoraria and research funding from Eisai. Dr. Terui has received honoraria form Janssen. Dr. Tsukasaki has received research funding from Eisai, Celgene, Takeda, and Mundipharma; and has received honoraria from Zenyaku Kogyo, HUYA, and Chugai. Dr. Usuki has received honoraria from Nippon Shinyaku, MSD, Kyowa Hakko Kirin, Novartis, Bristol-Meyer-Squibb, and Dainippon Sumitomo. Dr. Kinoshita has received research funding form Eisai, Solasia, and has received honoraria from Eisai, Zenyaku Kogyo, Janssen, Chugai, and Kyowa Hakko Kirin. Dr. Suzumiya has received research funding from Eisai, Kyowa Hakko Kirin, Chugai, Astellas, and Toyama Chemical; and has received honoraria from Eisai, Chugai, and Takeda. Dr. Nagai has received research funding from CIMIC, Janssen, Mundipharma, Takeda, Bristol-Myers Squibb, and Otsuka; and has received honoraria from Chugai. GY has received honoraria form Takeda, Celgene, and Janssen. Dr. Tobinai has received research funding from Eisai, Chugai, Kyowa Hakko Kirin, Ono, Celgene, Janssen, GlaxoSmithKline, Mundipharma, Takeda, Servier, and AbbVie; and has received honoraria from Eisai, Janssen, Mundipharma, Takeda, Zenyaku Kogyo, and HUYA.All remaining authors have declared no conflicts of interest.
Free to read: This content has been made available to all.